Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights

Legend Biotech Corporation , through its wholly owned subsidiary, Legend Biotech Ireland Limited, entered into an exclusive, global license agreement with Novartis Pharma AG. The Company granted...

Related Keywords

Germany ,Belgium ,Ireland ,New Jersey ,United States ,Ying Huang ,Janssen Biotech Inc ,European Myeloma Network ,University Of Virginia ,Agency For Medicines ,Foreign Affairs ,Exchange Commission ,Development Expenses ,Global Development Plan ,Twitter ,Linkedin ,Legend Biotech Corporation ,Novartis ,Legend Biotech Ireland ,Health Products ,University Of Virginia School Law Cash ,Biotech Reports Third Quarter ,Recent Highlights ,Biotech Corporation ,Legend Biotech ,Legend Biotech Ireland Limited ,Novartis Pharma ,Federal Agency ,Janssen Agreement ,Jim Pepin ,Senior Vice President ,General Counsel ,Corporate Secretary ,Vice President ,Nestle Healthcare Nutrition ,Juris Doctor ,Virginia School ,Chief Executive Officer ,Directed Chimeric Antigen Receptort Cells ,Ciltacabtagene Autoleucel Versus Daratumumab ,Autologous Stem Cell Transplant ,Quarter Ended September ,Cash Equivalents ,Time Deposits ,Janssen Biotech ,Investigational New Drug ,Conference Call Details ,Private Securities Litigation Reform Act ,Annual Report ,Months Ended September ,Business Wire ,Markets ,